Docetaxel: Overview of an Active Drug for Breast Cancer

John Crown
The Oncologist 2001; 6(Suppl 3): 1-4; doi:10.1634/theoncologist.6-suppl_3-1
[Abstract] [Full Text] [PDF]  

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

Jean-Marc Nabholtz, Alessandro Riva
The Oncologist 2001; 6(Suppl 3): 5-12; doi:10.1634/theoncologist.6-suppl_3-5
[Abstract] [Full Text] [PDF]  

Docetaxel and Epirubicin in Advanced Breast Cancer

Cristiana Sessa, Olivia Pagani
The Oncologist 2001; 6(Suppl 3): 13-16; doi:10.1634/theoncologist.6-suppl_3-13
[Abstract] [Full Text] [PDF]  

Nonanthracycline Containing Docetaxel-Based Combinations in Metastatic Breast Cancer

John Crown
The Oncologist 2001; 6(Suppl 3): 17-21; doi:10.1634/theoncologist.6-suppl_3-17
[Abstract] [Full Text] [PDF]  

Docetaxel and Herceptin: Foundation for Future Strategies

Mark D. Pegram
The Oncologist 2001; 6(Suppl 3): 22-25; doi:10.1634/theoncologist.6-suppl_3-22
[Abstract] [Full Text] [PDF]  

Weekly Docetaxel in Breast Cancer: Applying Clinical Data to Patient Therapy

Jose Baselga, Josep M. Tabernero
The Oncologist 2001; 6(Suppl 3): 26-29; doi:10.1634/theoncologist.6-suppl_3-26
[Abstract] [Full Text] [PDF]  

Theoretical Concepts and the Emerging Role of Taxanes in Adjuvant Therapy

Larry Norton
The Oncologist 2001; 6(Suppl 3): 30-35; doi:10.1634/theoncologist.6-suppl_3-30
[Abstract] [Full Text] [PDF]  

Neoadjuvant Therapy in Breast Cancer: Can We Define Its Role?

Matti S. Aapro
The Oncologist 2001; 6(Suppl 3): 36-39; doi:10.1634/theoncologist.6-suppl_3-36
[Abstract] [Full Text] [PDF]  

Novel Compounds in the Therapy of Breast Cancer: Opportunities for Integration with Docetaxel

Anthony W. Tolcher
The Oncologist 2001; 6(Suppl 3): 40-44; doi:10.1634/theoncologist.6-suppl_3-40
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.